Urological Care and COVID-19: Looking Forward.

COVID-19 management organization surgery urology

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 21 04 2020
accepted: 24 06 2020
entrez: 15 8 2020
pubmed: 15 8 2020
medline: 15 8 2020
Statut: epublish

Résumé

The recent COVID-19 pandemic represents a worldwide emergency and it is affecting healthcare at every level, including also urological care and especially oncologic patients. Recent epidemiological models show that, without effective treatment or vaccine, there will be a long-lasting phase of cohabitation with the virus. Current experts' opinions recommend performing only non-deferrable uro-oncological surgery and postponing other activities until the end of the emergency, with particular concerns regarding the safety laparoscopy. Veneto Region and Padua Province represent one of the first site of the pandemic spread of the virus outside China, thus we present our experience as a Urological Referral Center in applying a segregated-team work model of organization during the month of March 2020, with a stratified organization of activities, adequate screening and protection for patients and staff were adopted. Compared to the same period of last year even if a 19.5% reduction was experienced in overall surgical activity while maintaining a comparable proportion of oncologic robotic and laparoscopic surgery and guaranteeing care also for high priority non-oncological patients. No cases of COVID-19 infection were reported in staff members nor in patients and the number of surgical complications was comparable to that of last year. Therefore, in our opinion the recommended significant reduction in urological care, including surgical activities, is likely unrealistic in the long period with unknown effects affecting mostly oncological patients. Our experience introducing a segregated-team work model might represent a model for future planning.

Identifiants

pubmed: 32793504
doi: 10.3389/fonc.2020.01313
pmc: PMC7386309
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1313

Informations de copyright

Copyright © 2020 Prayer-Galetti, Motterle, Morlacco, Celso, Boemo, Iafrate and Zattoni.

Références

J Urol. 2020 Jul;204(1):7-8
pubmed: 32249664
Eur Urol. 2020 Jun;77(6):663-666
pubmed: 32279903
BJU Int. 2020 Jun;125(6):E7-E14
pubmed: 32249538
BJU Int. 2020 Jun;125(6):E3-E4
pubmed: 32232915
Surgery. 2000 Feb;127(2):117-26
pubmed: 10686974
J Am Acad Dermatol. 1995 Mar;32(3):436-41
pubmed: 7868712
Anesthesiology. 2019 Jul;131(1):58-73
pubmed: 30882475
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Inflamm Allergy Drug Targets. 2015;13(6):367-70
pubmed: 26021321
Minerva Urol Nefrol. 2020 Jun;72(3):376-383
pubmed: 32225135
World J Surg. 2020 Jun;44(6):1695-1698
pubmed: 32246185
Emerg Microbes Infect. 2020 Dec;9(1):386-389
pubmed: 32065057
Eur Urol. 2020 Jul;78(1):21-28
pubmed: 32376137
Curr Opin Urol. 2018 Mar;28(2):153-158
pubmed: 29232271
Nat Rev Urol. 2020 May;17(5):251-253
pubmed: 32203310
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
BMJ. 2020 Mar 18;368:m1106
pubmed: 32188602
J Minim Invasive Gynecol. 2020 May - Jun;27(4):792-793
pubmed: 32251839
J Urol. 2020 Jul;204(1):11-13
pubmed: 32249715
J Am Acad Dermatol. 1989 Jul;21(1):41-9
pubmed: 2545749
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):872-877
pubmed: 29339300
Minerva Urol Nefrol. 2020 Jun;72(3):369-375
pubmed: 32202401
J Minim Invasive Gynecol. 2020 May - Jun;27(4):789-791
pubmed: 32247882
Ann Oncol. 2020 Jul;31(7):840-843
pubmed: 32243893

Auteurs

Tommaso Prayer-Galetti (T)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padua, Padua, Italy.

Giovanni Motterle (G)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padua, Padua, Italy.

Alessandro Morlacco (A)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padua, Padua, Italy.

Francesco Celso (F)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padua, Padua, Italy.

Deris Boemo (D)

Management Health Services Department, University Hospital of Padua, Padua, Italy.

Massimo Iafrate (M)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padua, Padua, Italy.

Filiberto Zattoni (F)

Clinica Urologica, Department of Surgical and Oncological Sciences, University of Padua, Padua, Italy.

Classifications MeSH